View Clinical Trial (Medical Research Study)
Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy - NCT00693485-(Clinical Trial 225054)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Artesia |
|
State:
|
|
CA |
| Zip Code: |
|
|
| Conditions: |
|
Glaucoma - Optic Neuropathy |
| Purpose: |
|
A multicenter, randomized, patient-masked, sham-controlled evaluation of the safety and
effects on visual function of brimonidine intravitreal implant in patients with glaucomatous
optic neuropathy. Patients will be followed for up to 1 year.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Primary open-angle glaucoma in one eye
- Visual acuity 20/80 or better
- Intraocular pressure in the study eye ≤ 24 mm Hg
- Glaucomatous visual field loss - 7 dB to - 25 dB
Exclusion Criteria:
- Known allergy to brimonidine tartrate
- Uncontrolled systemic disease or infection of the eye
- Recent eye surgery or injections in the eye
- Female patients who are pregnant, nursing or planning a pregnancy |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
September 9, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|